Cargando…

CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity

BACKGROUND: Aberrant β-catenin signaling plays a key role in several cancer types, notably colon, liver and breast cancer. However approaches to modulate β-catenin activity for therapeutic purposes have proven elusive to date. METHODOLOGY: To uncover genetic dependencies in breast cancer cells that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, So Young, Dunn, Ian F., Firestein, Ron, Gupta, Piyush, Wardwell, Leslie, Repich, Kara, Schinzel, Anna C., Wittner, Ben, Silver, Serena J., Root, David E., Boehm, Jesse S., Ramaswamy, Sridhar, Lander, Eric S., Hahn, William C.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813871/ https://www.ncbi.nlm.nih.gov/pubmed/20126544 http://dx.doi.org/10.1371/journal.pone.0008979

Ejemplares similares

Physiological regulation of β-catenin stability by Tcf3 and CK1ε
por: Lee, Ethan, et al.
Publicado: (2001)

CK1ε and p120‐catenin control Ror2 function in noncanonical Wnt signaling
por: Curto, Josué, et al.
Publicado: (2018)

The CK1δ/ϵ-Tip60 Axis Enhances Wnt/β-Catenin Signaling via Regulating β-Catenin Acetylation in Colon Cancer
por: Ning, Jiong, et al.
Publicado: (2022)

A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε
por: Dolde, Christine, et al.
Publicado: (2018)

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
por: Burger, Karen L., et al.
Publicado: (2023)

CK1ε drives osteogenic differentiation of bone marrow mesenchymal stem cells via activating Wnt/β-catenin pathway
por: Yu, Zhentang, et al.
Publicado: (2023)

Repositioning of Etravirine as a Potential CK1ε Inhibitor by Virtual Screening
por: Córdova-Bahena, Luis, et al.
Publicado: (2021)

Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1δ and CK1ε
por: Bischof, Joachim, et al.
Publicado: (2011)

CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch
por: Narasimamurthy, Rajesh, et al.
Publicado: (2018)

The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer
por: Wang, Zhongyuan, et al.
Publicado: (2021)

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
por: Barbie, David A., et al.
Publicado: (2009)

Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity
por: Cunningham, Peter S., et al.
Publicado: (2016)

Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
por: Bian, Jia, et al.
Publicado: (2020)

Novel Insights into the Biochemical Mechanism of CK1ε and its Functional Interplay with DDX3X
por: Bono, Bartolo, et al.
Publicado: (2020)

Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer
por: Dang, Fabin, et al.
Publicado: (2021)

Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration
por: Foldynová-Trantírková, Silvie, et al.
Publicado: (2010)

DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis
por: He, Tsung-Ying, et al.
Publicado: (2016)

REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma
por: Chen, Shaojun, et al.
Publicado: (2018)

Parallel nonfunctionalization of CK1δ/ε kinase ohnologs following a whole-genome duplication event
por: Evans-Yamamoto, Daniel, et al.
Publicado: (2023)

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2021)

CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin
por: Kendall, Jed J., et al.
Publicado: (2016)

CK19 Promotes Ovarian Cancer Development by Impacting on Wnt/β-Catenin Pathway
por: Lu, Qi, et al.
Publicado: (2020)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Altered Body Weight Regulation in CK1ε Null and tau Mutant Mice on Regular Chow and High Fat Diets
por: Zhou, Lili, et al.
Publicado: (2016)

Differential immunohistochemical expression of DEC1, CK-1ε, and CD44 in oral atypical squamous epithelium and carcinoma in situ
por: Sato, Fuyuki, et al.
Publicado: (2022)

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies
por: Davids, Matthew S., et al.
Publicado: (2021)

CRISPR-mediated gene targeting of CK1δ/ε leads to enhanced understanding of their role in endocytosis via phosphoregulation of GAPVD1
por: Guillen, Rodrigo X., et al.
Publicado: (2020)

Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma
por: Boricic, Novica, et al.
Publicado: (2022)

An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy
por: Kaur, Amanpreet, et al.
Publicado: (2022)

Umbralisib-Induced Immune-Mediated Colitis: A Concerning Adverse Effect of the Novel PI3Kδ/CK1ε Inhibitor
por: Bajaj, Suryansh, et al.
Publicado: (2021)

Z-Ajoene Inhibits Growth of Colon Cancer by Promotion of CK1α Dependent β-Catenin Phosphorylation
por: Li, Hua, et al.
Publicado: (2020)

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
por: Khilko, Natalya, et al.
Publicado: (2010)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer
por: Liu, Min, et al.
Publicado: (2020)

Behavioral and cognitive performance of humanized APOEε3/ε3 liver mice in relation to plasma apolipoprotein E levels
por: Kessler, Kat, et al.
Publicado: (2023)

CK 20‐positive and CK 7‐negative Merkel cell carcinoma of the cheek
por: Rai, Manoj Ponadka, et al.
Publicado: (2018)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε
por: Bischof, Joachim, et al.
Publicado: (2012)

Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways
por: Manni, Sabrina, et al.
Publicado: (2017)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9umidh4s85qk5pp30qi3nktk6c